Literature DB >> 27683689

Bone morphogenetic protein in pediatric spine fusion surgery.

Robert W Molinari1, Christine Kerr1, Danielle Kerr1.   

Abstract

BACKGROUND: There is a paucity of literature describing the use of bone graft substitutes to achieve fusion in the pediatric spine. Outcomes and complications involving the off-label use of bone morphogenetic protein 2 (BMP-2) in the pediatric spine are not clearly defined. The purpose of this study is to review the existing literature with respect to reported outcomes and complications involving the use of low-dose BMP-2 in pediatric patients.
METHODS: A Medline and PubMed literature search was conducted using the words bone morphogenetic protein, BMP, rh-BMP-2, bone graft substitutes, and pediatric spine.
RESULTS: To date, there are few published reports on this topic. Complications and appropriate BMP-2 dosage application in the pediatric spine remain unknown.
CONCLUSIONS: This report describes the potential for BMP-2 to achieve successful arthrodesis of the spine in pediatric patients. Usage should be judicious as complications and long-term outcomes of pediatric BMP-2 usage remain undefined in the existing literature.

Entities:  

Keywords:  Pediatric; bone morphogenetic protein (BMP); spine fusion

Year:  2016        PMID: 27683689      PMCID: PMC5039831          DOI: 10.21037/jss.2016.01.06

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  15 in total

Review 1.  Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.

Authors:  Chadi A Tannoury; Howard S An
Journal:  Spine J       Date:  2014-01-08       Impact factor: 4.166

2.  Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.

Authors:  Eugene J Carragee; Gilbert Chu; Rajat Rohatgi; Eric L Hurwitz; Bradley K Weiner; S Tim Yoon; Garet Comer; Branko Kopjar
Journal:  J Bone Joint Surg Am       Date:  2013-09-04       Impact factor: 5.284

3.  Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.

Authors:  Christina Sayama; Matthew Willsey; Murali Chintagumpala; Alison Brayton; Valentina Briceño; Sheila L Ryan; Thomas G Luerssen; Steven W Hwang; Andrew Jea
Journal:  J Neurosurg Pediatr       Date:  2015-04-10       Impact factor: 2.375

4.  Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery: an analysis of 4817 patients.

Authors:  Amit Jain; Khaled M Kebaish; Paul D Sponseller
Journal:  J Bone Joint Surg Am       Date:  2013-07-17       Impact factor: 5.284

5.  The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases.

Authors:  Kiril V Mladenov; Philip Kunkel; Ralf Stuecker
Journal:  Eur Spine J       Date:  2009-10-30       Impact factor: 3.134

6.  Bone morphogenetic protein for salvage fusion in an infant with Down syndrome and craniovertebral instability. Case report.

Authors:  Daniel C Lu; Peter P Sun
Journal:  J Neurosurg       Date:  2007-06       Impact factor: 5.115

Review 7.  Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature.

Authors:  Brandon G Rocque; Mick P Kelly; Joseph H Miller; Yiping Li; Paul A Anderson
Journal:  J Neurosurg Pediatr       Date:  2014-10-10       Impact factor: 2.375

8.  Under-reported complications related to BMP use in spine surgery.

Authors:  Per Aspenberg
Journal:  Acta Orthop       Date:  2011-10       Impact factor: 3.717

9.  Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2013-07-09

10.  The Use of Bone Morphogenetic Protein in Pediatric Cervical Spine Fusion Surgery: Case Reports and Review of the Literature.

Authors:  Robert W Molinari; Christine Molinari
Journal:  Global Spine J       Date:  2015-06-16
View more
  2 in total

1.  rhBMP2 alone does not induce macrophage polarization towards an increased inflammatory response.

Authors:  Emily L Durham; Rajiv Kishinchand; Zachary J Grey; James J Cray
Journal:  Mol Immunol       Date:  2019-11-20       Impact factor: 4.407

2.  Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Craniofacial Surgery.

Authors:  Elie P Ramly; Allyson R Alfonso; Rami S Kantar; Maxime M Wang; J Rodrigo Diaz Siso; Amel Ibrahim; Paulo G Coelho; Roberto L Flores
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.